ANVS
Annovis Bio, Inc.
NYSE · USHealthcareBiotechnology
$1.69-2.87%
Price as of Jul 20, 2026
ANVS analysis
Annovis Bio, Inc. stock analysis
Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.
Analysis for ANVS is not published yet
Browse the public research library while company-specific analysis is being prepared. Explore research